Science for a better life

Bayer is committed to working with cancer agencies and drug plans to bring innovative tumour agnostic treatment to Canadian patients

Bayer to advance two first-of-its-kind cell and gene therapies for Parkinson’s disease

Bayer brings “Feeding a Hungry Planet” into focus by inviting young leaders from Canada to apply for the 5th biennial Youth Ag Summit

Bayer’s finerenone meets primary endpoint in Phase III FIGARO-DKD cardiovascular outcomes study in patients with chronic kidney disease and type 2 diabetes